![David M. de Kretser](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David M. de Kretser
Hoofd Techniek/Wetenschap/O&O bij Paranta Biosciences Ltd.
Actieve functies van David M. de Kretser
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Paranta Biosciences Ltd.
![]() Paranta Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Paranta Biosciences Ltd. engages in the research and development of novel biotherapeutic. t develops PB01 (recombinant human follistatin-288) for the treatment of fibrotic and inflammatory diseases. The company was founded in 2011 and is headquartered in Richmond, Australia. | Directeur/Bestuurslid | - | - |
Hoofd Techniek/Wetenschap/O&O | - | - |
Loopbaan van David M. de Kretser
Statistieken
Internationaal
Australië | 2 |
Operationeel
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Paranta Biosciences Ltd.
![]() Paranta Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Paranta Biosciences Ltd. engages in the research and development of novel biotherapeutic. t develops PB01 (recombinant human follistatin-288) for the treatment of fibrotic and inflammatory diseases. The company was founded in 2011 and is headquartered in Richmond, Australia. | Health Technology |
- Beurs
- Insiders
- David M. de Kretser
- Ervaring